ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • Multitarget cardiovascular drugs
    Trstenjak, Uroš ; Kikelj, Danijel
    Cardiovascular disease is the number one cause of death globally. Design of cardiovascular drugs based on new paradigms is therefore a prominent goal of medicinal chemistry. Designed multiple ... ligands, targeting two or more proteinsinvolved in pathogenesis of disease have become a viable concept in drug discovery. Although adjustment of the activities ratio at the different targets is a demanding and challenging task, modulation of two or more targets involved in a cardiovascular disease June be more successful for therapeutic application than treatment directed against each target alone, because of improved pharmacodynamic and pharmacokinetic properties of designed multitarget drugs. The article reviews the applications of multi targetapproach to cardiovascular drug design, covering angiotensin-converting enzyme/neutral endopeptidase inhibitors, neutrale endopeptidase/endothelin-converting enzyme inhibitors, angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme inhibitors, dual angiotensin/endothelin receptor and angiotensin1/angotensin2 receptor antagonists and angiotensin receptor antagonist/neutral endopeptidase inhibitors.
    Source: Current medicinal chemistry. - ISSN 0929-8673 (Vol. 18, no. 17, 2011, str. 2531-2542)
    Type of material - article, component part
    Publish date - 2011
    Language - english
    COBISS.SI-ID - 3027569

source: Current medicinal chemistry. - ISSN 0929-8673 (Vol. 18, no. 17, 2011, str. 2531-2542)
loading ...
loading ...
loading ...